Search

everythinglearnresearchcommunity

for

Search:↓

Human exosomes are effective for targeted treatments but face scalability issues, while plant exosomes are cost-effective for cosmetics.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Skin aging can be slowed by targeting cells, hormones, and the microbiome.

Alzheimer's may be treated by targeting gut bacteria and inflammation.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Two microRNAs affect hair follicle development in sheep by targeting specific genes.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

TLR2 is important for hair growth and can be targeted to treat hair loss.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

mTORC1 activity is important for hair growth and color, and targeting it could help treat hair loss and greying.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.